Tata Chemicals Ltd
Tata Chemicals Ltd
ChemicalsKey Fundamentals
SmallcapCommodity ChemicalsChemicalsInsights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Tata Chemicals Ltd insights
50 extracted metrics + investor summaries across FY14–FY26.
Tapetide Score
Data-driven rating, 0–100. How it works →
Technical Indicators
Key Insights
Strengths
2- Stock is trading at 0.81 times its book value
- Company has been maintaining a healthy dividend payout of 82.4%
Weaknesses
3- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 7.41% over past five years.
- Company has a low return on equity of 1.59% over last 3 years.
Growth Rate
AI Analysis — Bull vs Bear
Tata Chemicals Ltd trades at a market cap of ₹17,298 Cr with a negative PE of -8.6x and a price-to-book of 0.81x, reflecting significant profitability challenges. The company's TTM profit has declined 193% while sales grew just 2%, indicating deep operational stress despite the Tata Group parentage and below-book valuation.
- Stock trades at 0.81x book value, offering a discount to net asset value which may provide a margin of safety for value-oriented investors
- Company maintains a healthy dividend payout ratio of 82.4% with a current dividend yield of 1.66%, providing income even during a down cycle
- 10-year stock CAGR of 13% demonstrates the company's ability to create long-term shareholder value through business cycles
- 5-year compounded sales growth of 7% indicates the underlying business has modest revenue expansion capability over medium-term horizons
- 10-year ROE average of 10% suggests the business has historically generated reasonable returns on equity before the recent downturn
- 5-year compounded profit growth of 3% shows that prior to the recent sharp decline, the company maintained marginal profitability growth
- Tata Group parentage provides access to capital, governance standards, and strategic support that could aid a turnaround
- TTM compounded profit has declined 193%, indicating the company has swung into losses and faces severe earnings deterioration
- Negative PE ratio of -8.6x confirms the company is currently loss-making, with no near-term earnings visibility from reported numbers
- 3-year compounded profit decline of 51% shows this is not a one-off issue but a sustained multi-year erosion of profitability
- 3-year ROE has collapsed to just 2% from a 10-year average of 10%, reflecting a structural decline in capital efficiency
- Last year ROE of only 1.59% demonstrates the business is barely generating any return on shareholders' equity
- Low interest coverage ratio signals that debt servicing is consuming a disproportionate share of operating profits, raising solvency concerns
- 1-year stock price decline of 30% and 3-year CAGR of -13% reflect sustained negative market sentiment and capital destruction
- 5-year sales growth of only 7.41% and 10-year compounded sales growth of 0% indicate the company has struggled to grow its topline meaningfully over long periods
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- Kenya mining halt notice Jul 29
Tata Chemicals' Kenya unit received a notice to halt mining and soda ash exports pending a compliance review by authorities. This creates uncertainty around Kenya-based soda ash operations during the review period.
- Consolidated EBITDA down 14% Jul 28
Consolidated EBITDA declined 14% in Q1FY27 due to weak overseas pricing, despite the revenue surge of 14.4% to ₹4,255 crore.
- Q1FY27 profit turnaround Jul 28
Tata Chemicals posted ₹60 crore consolidated net profit in Q1FY27, a turnaround from a ₹316 crore loss in Q1FY26, driven by a 14.4% revenue surge to ₹4,255 crore.
- Standalone profit up 11.7% Jul 28
Standalone net profit rose 11.7% to ₹343 crore in Q1FY27, indicating healthy domestic operations.
- ESG score of 67.8 assigned Jul 29
SES ESG Research independently assigned Tata Chemicals an adjusted ESG score of 67.8 for FY26 based on public data.
- New statutory auditor appointed Jul 27
Tata Chemicals appointed S R B C & CO. LLP as statutory auditors for five years starting from the 88th AGM in 2027, subject to shareholder approval.
- Q1FY27 earnings call held Jul 20
Tata Chemicals hosted an investor call on July 27, 2026 at 7:30 PM IST with MD & CEO R Mukundan and CFO Nandakumar Tirumalai to discuss Q1FY27 results.
TL;DR: Tata Chemicals delivered a meaningful profit turnaround in Q1FY27 with strong volume-led revenue growth of 14.4%, swinging from a ₹316 crore loss to ₹60 crore profit at the consolidated level. However, weak overseas pricing dragged consolidated EBITDA down 14%, and the Kenya mining halt notice introduces near-term operational risk to its soda ash exports. Domestic operations remain solid with standalone profit growing 11.7%. The trend is improving on volumes but overseas margin pressure and the Kenya regulatory situation need monitoring.
Quarterly Results
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4,218 | 3,998 | 3,730 | 3,475 | 3,789 | 3,999 | 3,590 | 3,509 | 3,719 | 3,877 | 3,550 | 3,438 | 4,255 |
| Expenses | 3,175 | 3,191 | 3,188 | 3,032 | 3,215 | 3,381 | 3,156 | 3,182 | 3,070 | 3,340 | 3,205 | 3,164 | 3,717 |
| Operating Profit | 1,043 | 807 | 542 | 443 | 574 | 618 | 434 | 327 | 649 | 537 | 345 | 274 | 538 |
| OPM % | 25% | 20% | 15% | 13% | 15% | 15% | 12% | 9% | 17% | 14% | 10% | 8% | 13% |
| Other Income | 67 | 187 | 98 | -861 | 116 | 152 | -10 | 29 | 138 | 128 | 21 | -1,760 | 56 |
| Interest | 123 | 145 | 132 | 130 | 133 | 145 | 148 | 137 | 147 | 144 | 146 | 153 | 148 |
| Depreciation | 229 | 234 | 246 | 271 | 273 | 277 | 280 | 293 | 280 | 285 | 293 | 343 | 336 |
| PBT | 758 | 615 | 262 | -819 | 284 | 348 | -4 | -74 | 360 | 236 | -73 | -1,982 | 110 |
| Tax % | 23% | 20% | 26% | 3% | 33% | 23% | 425% | -34% | 12% | 35% | -5% | 7% | 45% |
| Net Profit | 587 | 495 | 194 | -841 | 190 | 267 | -21 | -49 | 316 | 154 | -69 | -2,116 | 60 |
| EPS in Rs | 20.88 | 16.8 | 6.2 | -33.36 | 5.89 | 7.61 | -2.08 | -2.2 | 9.89 | 3.02 | -3.65 | -83.67 | -0.67 |
Profit & Loss
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 17,204 | 14,873 | 10,346 | 10,270 | 10,337 | 10,357 | 10,200 | 12,622 | 16,789 | 15,421 | 14,887 | 14,584 | 15,120 |
| Expenses | 15,305 | 12,777 | 8,249 | 6,926 | 8,538 | 8,411 | 8,693 | 10,303 | 12,969 | 12,574 | 12,934 | 12,779 | 13,426 |
| Operating Profit | 1,900 | 2,096 | 2,097 | 3,344 | 1,799 | 1,945 | 1,506 | 2,319 | 3,820 | 2,847 | 1,953 | 1,805 | 1,694 |
| OPM % | 11% | 14% | 20% | 33% | 17% | 19% | 15% | 18% | 23% | 18% | 13% | 12% | 11% |
| Other Income | 183 | 210 | 293 | 262 | 785 | 6,480 | 254 | 472 | 218 | -507 | 287 | -1,473 | -1,555 |
| Interest | 461 | 525 | 297 | 326 | 354 | 342 | 367 | 303 | 406 | 530 | 563 | 590 | 591 |
| Depreciation | 463 | 526 | 512 | 518 | 568 | 666 | 759 | 806 | 892 | 980 | 1,123 | 1,201 | 1,257 |
| PBT | 1,159 | 1,255 | 1,580 | 2,763 | 1,661 | 7,416 | 634 | 1,682 | 2,740 | 830 | 554 | -1,459 | -1,709 |
| Tax % | 30% | 20% | 22% | 2% | 17% | 3% | 31% | 16% | 11% | 46% | 30% | 18% | — |
| Net Profit | 802 | 1,006 | 1,234 | 2,702 | 1,387 | 7,228 | 436 | 1,405 | 2,434 | 435 | 387 | -1,715 | -1,971 |
| EPS in Rs | 23.41 | 30.24 | 38.98 | 95.49 | 45.37 | 275 | 10.06 | 49.36 | 90.93 | 10.52 | 9.22 | -74.41 | -84.97 |
| Div. Payout % | 53% | 33% | 28% | 23% | 28% | 4% | 99% | 25% | 19% | 143% | 119% | -15% | — |
Balance Sheet
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 255 | 255 | 255 | 255 | 255 | 255 | 255 | 255 | 255 | 255 | 255 | 255 |
| Reserves | 5,297 | 6,600 | 7,653 | 10,847 | 12,086 | 12,643 | 14,035 | 17,998 | 19,466 | 21,986 | 21,339 | 20,951 |
| Borrowings | 8,379 | 9,090 | 7,072 | 6,108 | 6,130 | 7,702 | 6,933 | 7,025 | 6,296 | 5,563 | 7,072 | 8,001 |
| Other Liabilities | 6,872 | 8,402 | 8,607 | 8,648 | 8,398 | 7,073 | 7,115 | 8,566 | 8,923 | 8,907 | 9,084 | 9,791 |
| Total Liabilities | 20,802 | 24,346 | 23,587 | 25,858 | 26,869 | 27,673 | 28,337 | 33,843 | 34,940 | 36,711 | 37,750 | 38,998 |
| Fixed Assets | 11,359 | 13,431 | 12,644 | 12,787 | 13,551 | 15,356 | 15,261 | 16,044 | 17,092 | 17,861 | 19,600 | 20,602 |
| CWIP | 189 | 350 | 333 | 409 | 774 | 835 | 1,094 | 1,667 | 2,410 | 2,217 | 1,913 | 1,038 |
| Investments | 443 | 2,188 | 2,787 | 2,840 | 5,615 | 4,285 | 5,816 | 7,683 | 7,448 | 9,739 | 9,144 | 9,886 |
| Other Assets | 8,811 | 8,377 | 7,822 | 9,822 | 6,929 | 7,198 | 6,167 | 8,449 | 7,990 | 6,894 | 7,093 | 7,472 |
| Total Assets | 20,802 | 24,346 | 23,587 | 25,858 | 26,869 | 27,673 | 28,337 | 33,843 | 34,940 | 36,711 | 37,750 | 38,998 |
Cash Flow
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 1,274 | 2,332 | 3,531 | 1,870 | 1,581 | 1,780 | 2,037 | 1,644 | 2,971 | 3,016 | 1,761 | 1,269 |
| Investing | -663 | -463 | -985 | 2,714 | -1,927 | -2,285 | -1,147 | -817 | -1,149 | -605 | -1,667 | -766 |
| Financing | -1,087 | -1,802 | -2,341 | -2,089 | -1,712 | -129 | -1,456 | -755 | -2,076 | -2,494 | 29 | -670 |
| Net Cash Flow | -477 | 68 | 205 | 2,494 | -2,058 | -634 | -565 | 72 | -254 | -83 | 123 | -167 |
| Free Cash Flow | 709 | 1,645 | 2,888 | 1,140 | 502 | 611 | 804 | 379 | 1,427 | 1,193 | -191 | 129 |
| CFO/OP | 86 | 129 | 190 | 71 | 115 | 99 | 142 | 82 | 88 | 120 | 102 | 67 |
Ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 73 | 88 | 74 | 46 | 51 | 56 | 50 | 56 | 57 | 45 | 47 | 52 |
| Inventory Days | 137 | 119 | 244 | 304 | 315 | 347 | 257 | 317 | 282 | 341 | 324 | 353 |
| Days Payable | 138 | 99 | 232 | 307 | 269 | 302 | 256 | 338 | 289 | 320 | 318 | 293 |
| Cash Conversion Cycle | 72 | 107 | 86 | 43 | 97 | 100 | 51 | 35 | 50 | 66 | 53 | 113 |
| Working Capital Days | -4 | 31 | -4 | 27 | -2 | -102 | -28 | -29 | 29 | -22 | -21 | -17 |
| ROCE % | 11% | 11% | 10% | 16% | 9% | 36% | 4% | 8% | 12% | 8% | 4% | 3% |
Documents
Frequently Asked Questions about Tata Chemicals Ltd
What does Tata Chemicals Ltd do?
Where is Tata Chemicals Ltd (TATACHEM) listed?
Which sector does Tata Chemicals Ltd belong to?
What is the market capitalisation of Tata Chemicals Ltd?
What is the PE ratio of Tata Chemicals Ltd?
What is the 52-week high and low of Tata Chemicals Ltd?
Does Tata Chemicals Ltd pay dividends?
What is the Return on Equity (ROE) of Tata Chemicals Ltd?
How can I research Tata Chemicals Ltd on Tapetide?
Company Information
Incorporated in 1939, Tata Chemicals Ltd manufactures and exports basic chemistry and specialty products [1]